INSULIN RESISTANCE MARKERS IN PATIENTS WITH ST SEGMENT ELEVATION MYOCARDIAL INFARCTION

QR Code

INSULIN RESISTANCE MARKERS IN PATIENTS WITH ST SEGMENT ELEVATION MYOCARDIAL INFARCTION

In general population and among diabetic patients, insulin resistance (IR) is regarded as a cardiovascular risk factor. The aim of this study was to assess the dynamics of IR markers among non-diabetic and diabetic (Type 2 diabetes mellitus, DM-2) patients with acute myocardial infarction and ST seg...

Full description

Saved in:

Bibliographic Details
Main Authors:	O. V. Gruzdeva, O. L. Barbarash, O. E. Akbasheva, E. I. Palicheva, V. V. Kashtalap, Yu. A. Dyleva, A. A. Silonova, E. V. Tavlueva
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2011-12-01
Series:	Российский кардиологический журнал
Subjects:	dynamics of insulin resistance markers st segment elevation acute myocardial infarction type 2 diabetes mellitus reconvalescent phase
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/1166
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

LEFT VENTRICULAR REMODELING IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION WITH AND WITHOUT ST SEGMENT ELEVATION
by: N. E. Zakirova, et al.
Published: (2016-05-01)

ELECTROCARDIOGRAM ST SEGMENT DEPRESSION AND ELEVATION IN STRESS-TESTING
by: D. A. Kuzhel, et al.
Published: (2015-09-01)

Dose-dependent effects of atorvastatin in the hospitalisation period of myocardial infarction
by: O. L. Barbarash, et al.
Published: (2013-06-01)

THE RELEVANCE OF THROMBOLYTIC THERAPY IN ST ELEVATION MYOCARDIAL INFARCTION
by: N. V. Teplova, et al.
Published: (2014-05-01)

THROMBOLYSIS OR PRIMARY PCI FOR MYOCARDIAL INFARCTION WITH ST-SEGMENT ELEVATION? THE STREAM TRIAL (STRATEGIC REPERFUSION EARLY AFTER MYOCARDIAL INFARCTION)
by: V. A. Sulimov
Published: (2015-09-01)

Annual personalised calculator for prognostication after ST-segment elevation myocardial infarction
by: V. B. Barbarich, et al.
Published: (2020-06-01)

In-hospital outcomes of ST elevation myocardial infarction in post-COVID-19 patients
by: M. G. Chashchin, et al.
Published: (2023-03-01)

Heart rate variability in patients with acute ST-segment elevation myocardial infarction after COVID-19
by: V. P. Mikhin, et al.
Published: (2023-11-01)

PHARMACOEPIDEMIOLOGIC ANALYSIS OF ST-ELEVATION MYOCARDIAL INFARCTION REPERFUSION THERAPY AT SARATOV REGION HOSPITALS OF DIFFERENT TYPES
by: O. V. Reshetko, et al.
Published: (2016-01-01)

SYNTAX residual in long-term outcomes prognosis of endovascular revascularization in myocardial infarction with ST elevation and multivessel disease
by: R. S. Tarasov, et al.
Published: (2016-10-01)

Serum markers of cardiac fibrosis suffering from heart failure with preserved left ventricular ejection fraction upon ST-segment elevation myocardial infarction
by: A. V. Оsokina, et al.
Published: (2021-09-01)

Prediction of in-hospital mortality in patients with ST-segment elevation acute myocardial infarction after percutaneous coronary intervention
by: B. I. Geltser, et al.
Published: (2023-07-01)

Clinical significance of plasma osmolarity in acute heart failure in patients with ST-segment elevation myocardial infarction
by: L. I. Malinova, et al.
Published: (2025-02-01)

THE RESULTS OF A VARIETY OF STRATEGIES APPLICATION IN PRIMARY PERCUTANEOUS INTERVENTION IN ST ELEVATION MYOCARDIAL INFARCTION PATIENTS AND MULTIVESSEL DISEASE ACCORDING TO THE GRADE OF LESION SEVERITY BY SYNTAX SCORE
by: R. S. Tarasov, et al.
Published: (2015-04-01)

ENDOTHELIAL DYSFUNCTION MARKERS IN PATIENTS WITH NON-ST ELEVATION ACUTE CORONARY SYNDROME AND MULTIFOCAL ATHEROSCLEROSIS
by: S. A. Berns, et al.
Published: (2013-12-01)

The role of <i>SELE</i> gene polymorphism in ST-elevation myocardial infarction
by: N. P. Babushkina, et al.
Published: (2025-03-01)

2024 Clinical practice guidelines for Acute myocardial infarction with ST segment elevation electrocardiogram
by: O. V. Averkov, et al.
Published: (2025-04-01)

CLINICAL AND BIOCHEMICAL PREDICTORS OF DIABETES MELLITUS MANIFESTATION AFTER MYOCARDIAL INFARCTION
by: O. L. Barbarash, et al.
Published: (2014-03-01)

Prospective registry of non-ST-elevation acute coronary syndrome in a regional vascular center (CONTRAST). Study design and outcomes of the hospital stage
by: S. Yu. Martsevich, et al.
Published: (2025-05-01)

Contemporary Trends and Age‐Specific Sex Differences in Management and Outcome for Patients With ST‐Segment Elevation Myocardial Infarction
by: Leonardo De Luca, et al.
Published: (2016-12-01)

COMPARATIVE RESULTS OF RECOMBINANT NON-IMMUNOGENIC STAPHYLOKINASE AND TENECTEPLASE USE IN ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION IN REAL CLINICAL PRACTICE
by: E. S. Mazur, et al.
Published: (2017-09-01)

EFFECTS OF CARVEDILOL ON PLATELET AGGREGATION IN MEN WITH ST-ELEVATION ACUTE MYOCARDIAL INFARCTION
by: A. N. Zakirova, et al.
Published: (2016-01-01)

TENEKTEPLASE: NEW POSSIBILITIES FOR SYSTEMIC THROMBOLYTIC THERAPY OF ACUTE CORONARY SYNDROME WITH ST-SEGMENT ELEVATION
by: N. A. Novikova, et al.
Published: (2016-01-01)

Clinical and epidemiological evolution of modern therapy and measles in children
by: V. N. Timchenko, et al.
Published: (2015-04-01)

MANAGEMENT OF PATIENTS WITH ST-SEGMENT ELEVATION ACUTE CORONARY SYNDROME IN INTERVENTIONAL CARDIOLOGY UNITS: RECORD-3 REGISTRY DATA
by: Olga L. Barbarash, et al.
Published: (2016-09-01)

Double Culprits in a Patient with ST Elevation Myocardial Infarction: A Challenging But Rewarding Case
by: Eka Ginanjar, et al.
Published: (2018-06-01)

Double Culprits in a Patient with ST Elevation Myocardial Infarction: A Challenging But Rewarding Case
by: Eka Ginanjar, et al.
Published: (2018-06-01)

MONITORING OF THE EFFICACY AND SAFETY OF HIGH-DOSE ATORVASTATIN IN ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION
by: L. I. Salyamova, et al.
Published: (2018-05-01)

EVOLUTION OF THROMBOLYTIC THERAPY IN THE TREATMENT OF MYOCARDIAL INFARCTION
by: P. G. Kesov, et al.
Published: (2015-09-01)

Revascularization of myocardial infarction without ST segment elevation in multivessel coronary artery disease
by: Sh. J. Khalilov, et al.
Published: (2024-10-01)

2020 Clinical practice guidelines for Acute coronary syndrome without ST segment elevation
by: O. L. Barbarash, et al.
Published: (2021-05-01)

RISKS AND BENEFITS OF REPERFUSION STRATEGIES IN ACUTE MYOCARDIAL INFARCTION WITH ST SEGMENT ELEVATION
by: T. M. Poponina, et al.
Published: (2010-10-01)

Determination of the infarct‐related artery in patients with myocardial infarction without ST segment elevation
by: Sh. J. Khalilov
Published: (2024-04-01)

Adiponectin and insulin: molecular mechanisms of metabolic disorders
by: E. G. Uchasova, et al.
Published: (2020-10-01)

Predictors of acute kidney injury in patients with ST-segment elevation myocardial infarction complicated by cardiogenic shock who underwent percutaneous coronary intervention
by: O. V. Arsenicheva
Published: (2022-09-01)

Genetic markers of risk for ST-elevated myocardial infarction
by: N. G. Lozhkina, et al.
Published: (2019-11-01)

Non-ST-elevation myocardial infarction: dual etiology, twoway therapy
by: Mihály Medvegy, et al.
Published: (2025-07-01)

Analysis of outcomes in patients with ST-segment elevation myocardial infarction aged 90 years and older: a single center experience
by: P. D. Duplyakova, et al.
Published: (2023-12-01)

Fortelyzin® in comparison with Metalyse® for ST-elevated myocardial infarction: one-year results and clinical outcomes of a multicenter randomized study FRIDOM1
by: V. A. Markov, et al.
Published: (2018-12-01)

ST-segment elevation acute coronary syndrome in a child with Duchenne muscular dystrophy: a case report
by: Z. G. Tatarintseva, et al.
Published: (2024-12-01)